Reumatrix is a service for the reumatologists wiliing to have a mobile service to support the management of the patient suffering of rheumatoid arthritis (RA). It allows to identify the rapid radiographic progreession risk (RRP), an important parameter to lead the approriate clinical and therapeutic management of the patient. Based on literature data*, this app allows to identify the RRP risk in early or stable patients treated with metotrexate monotherapy or monotrexate+infliximab dual therapy and to calculate the related risks. (*Vastesaeger N, et al. A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis. Rheumatology 2009; 48:1114-1121). ACCESS IS RESTRICTED TO HOSPITALS PHYSICIANS AND PHARMACISTS To use the App you must be registered with the site Univadis. If you are a
hospital physician or pharmacist and you are not registered with the site,
go to www.univadis.it to register and be enabled to use the App.less
|
